A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours

Research and development of next generation of antibody-based therapeutics

(2010) Jing Li et al.   ACTA PHARMACOLOGICA SINICA

Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours

(2010) T Gelardi et al.   BRITISH JOURNAL OF CANCER

Tocilizumab

(2010) Adith Venkiteshwaran   mAbs

Targeted HER2 Treatment in Advanced Gastric Cancer

(2010) Jan Trøst Jørgensen   ONCOLOGY

Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents

(2009) Gennaro Riccio et al.   FASEB JOURNAL

Human anti-ErbB2 immunoagents - immunoRNases and compact antibodies

(2009) Claudia De Lorenzo et al.   FEBS Journal

Human antibody RNase fusion protein targeting CD30+ lymphomas

(2008) C. Menzel et al.   BLOOD

From ImmunoToxins to ImmunoRNases

(2008) Claudia Lorenzo et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY